AASLD News

AASLD is now accepting comments on proposed updates to AASLD's Practice Guidance on the Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (formerly NAFLD), which will now include new treatment guidance. AASLD invites stakeholders to review the draft guidance updates before they are finalized and published by providing comments now through 8/22/24

Today, I’m writing to ask for your help responding to a proposal that could undermine liver disease research at the National Institutes of Health (NIH). House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) released a framework to reform the NIH, which would be massively disruptive to the agency and the research that it funds. The framework was developed without the benefit of

Alexandria, VA—The American Association for the Study of Liver Diseases (AASLD) is excited to announce that applications are now open to participate in the highly anticipated Academic Debate at the 75 th annual Liver Meeting® (TLM) in San Diego, CA. This is a unique opportunity for hepatology professionals to showcase their expertise, engage in spirited discussion, and contribute to advancing the

Alexandria, VA—The American Association for the Study of Liver Disease (AASLD) is delighted to announce the 2025 calendar of events. The calendar is packed with educational opportunities to advance—or contribute to—the understanding and treatment of liver disease. Listed in Chronological Order. SLD and MetALD Emerging Topic Conference Date: February 27-March 1, 2025 Description: In collaboration

Alexandria, VA—The American Association for the Study of Liver Diseases (AASLD) is pleased to announce that applications are now open for its 2024 Women's Initiative Committee (WIC) Leadership Program . The committee aims to support and empower women in hepatology through mentorship, professional development education, and networking. The Women's Leadership Program (WLP) is a 12-month program

Alexandria, VA – The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest medical society funding source for liver disease research and training in the United States, announced today a funding commitment of over $2.6 million 150 grantees. This funding will support research projects aimed at advancing the understanding, prevention, diagnosis, and treatment of liver

The American Association for the Study of Liver Diseases (AASLD) is committed to producing practice guidelines that are trustworthy, methodologically sound, and rigorous, and adhere to the highest existing standards. AASLD recognizes that programs should be regularly reviewed and modified as the needs of the community and the association strategies evolve. As a result of this, the practice

Incoming Councilor Incoming Secretary Incoming Foundation Board Trustee For more information on the new leadership and to view the candidates for Councilor at Large and the 2025 Nominating Committee, please click here .

AASLD is pleased to announce the selection of sixty-two hepatology leaders as Fellows and one allied health leader focused on hepatology as an Associate Fellow. The Fellows Programs bestows honorary recognition upon AASLD members who have made a significant contribution to the knowledge and/or practice of liver and biliary diseases, and are considered leaders in the field. Associate Fellow of the

This morning the American Association for the Study of Liver Diseases (AASLD) unintentionally released an acknowledgment of a positive FDA ruling on Madrigal's MASH therapy. Like many in the field, AASLD is anticipating a ruling soon and prepared a statement in advance. Unfortunately, this communication was issued prematurely and in error. We have no knowledge of any FDA ruling and apologize for

We’re excited to announce there’s another opportunity to share your insights and present your findings at Digestive Disease Week® (DDW) 2024 . DDW is now accepting clinical and basic science Late-Breaking Abstract submissions through March 20. Submissions should feature newsworthy, high-impact data that was not available at the general submission deadline. This is a great opportunity to widen your

Alexandria, VA – The American Association for the Study of Liver Diseases (AASLD) today announced the sunsetting of their esteemed journal, Clinical Liver Disease ( CLD ). First published in 2012, CLD is a multimedia journal that provides education for clinicians diagnosing and managing patients with liver disease. “As we navigate the rapidly evolving landscape of technology and educational

Alexandria, VA – As part of AASLD’s commitment to championing diversity, equity, and inclusion (DEI) within the field of hepatology, AASLD is pleased to announce the inaugural recipient of the Harold Amos Medical Faculty Development Program Hepatology Award, Ashley L. Spann, MD, MSACI of Vanderbilt University Medical Center . Dr. Spann is an Assistant Professor of Medicine in the Division of

Alexandria, VA –AASLD proudly announces the distinguished leadership of Dr. Ray Kim as its 2024 President. Dr. Kim, a renowned hepatologist and esteemed global researcher, assumed the role of President on January 1, bringing his wealth of experience and commitment to advancing liver disease research, education, and improved patient care. W. Ray Kim, MD, MBA, FAASLD currently serves as Professor of